title: Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger.
abstract: Cerebral edema forms in the early hours of ischemic stroke by processes involving increased transport of Na and Cl from blood into brain across an intact blood-brain barrier (BBB). Our previous studies provided evidence that the BBB Na-K-Cl cotransporter is stimulated by the ischemic factors hypoxia, aglycemia, and arginine vasopressin (AVP), and that inhibition of the cotransporter by intravenous bumetanide greatly reduces edema and infarct in rats subjected to permanent middle cerebral artery occlusion (pMCAO). More recently, we showed that BBB Na/H exchanger activity is also stimulated by hypoxia, aglycemia, and AVP. The present study was conducted to further investigate the possibility that a BBB Na/H exchanger also participates in edema formation during ischemic stroke. Sprague-Dawley rats were subjected to pMCAO and then brain edema and Na content assessed by magnetic resonance imaging diffusion-weighed imaging and magnetic resonance spectroscopy Na spectroscopy, respectively, for up to 210 minutes. We found that intravenous administration of the specific Na/H exchange inhibitor HOE-642 significantly decreased brain Na uptake and reduced cerebral edema, brain swelling, and infarct volume. These findings support the hypothesis that edema formation and brain Na uptake during the early hours of cerebral ischemia involve BBB Na/H exchanger activity as well as Na-K-Cl cotransporter activity.
authors.affiliation: Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, California 95616, USA. meodonnell@ucdavis.edu
authors.forename: Martha E
authors.initials: ME
authors.lastname: O'Donnell
authors.forename: Yi-Je
authors.initials: YJ
authors.lastname: Chen
authors.forename: Tina I
authors.initials: TI
authors.lastname: Lam
authors.forename: Kelleen C
authors.initials: KC
authors.lastname: Taylor
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Walton
authors.forename: Steven E
authors.initials: SE
authors.lastname: Anderson
mesh_terms: D061605:Administration, Intravenous; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001812:Blood-Brain Barrier / Q000378:metabolism / Q000473:pathology; D001929:Brain Edema / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D020520:Brain Infarction / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D006146:Guanidines / Q000494:pharmacology*; D020244:Infarction, Middle Cerebral Artery; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*; D020521:Stroke / Q000188:drug therapy* / Q000378:metabolism; D013450:Sulfones / Q000494:pharmacology*
chemical_list: D000889:Anti-Arrhythmia Agents; D006146:Guanidines; D009419:Nerve Tissue Proteins; D017923:Sodium-Hydrogen Exchangers; D013450:Sulfones; C093373:cariporide; D012964:Sodium